virus gene-recombinant vaccine (Eyegene)

N/A

Report date: 2025/03/20 14:41:24

Base Information

Drug Namevirus gene-recombinant vaccine (Eyegene)
Drug Alias NameN/A
ClassificationVaccines > Development/production technology > Recombinant vector vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsEncephalitis, Japanese
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEyegene Inc
China Registration ClassN/A

Develop Information

Active CompaniesEyegene Inc
Inactive CompaniesN/A
Active IndicationsEncephalitis, Japanese
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A